Market Overview

According to fortune business insights, the global conversational AI in healthcare market size was valued at USD 2.29 billion in 2025. The market is projected to grow from USD 2.98 billion in 2026 to USD 24.50 billion by 2034, exhibiting a CAGR of 30.11% during the forecast period. North America dominated the conversational AI in healthcare market with a market share of 44.10% in 2025.

The analysis shows that the market is driven by rising healthcare call volumes, increasing administrative burdens on clinicians, and growing demand for continuous digital patient access. Healthcare providers, payers, and pharma companies are adopting these tools, which are evolving from rule-based chatbots to generative AI assistants, to improve communication and reduce manual workloads.

Major Players Profiled in the Market Report:

• Microsoft (U.S.)
• Abridge Al, Inc. (U.S.)
• Ada Health GmbH (Germany)
• Suki AI, Inc. (U.S.)
• Kore.ai Inc. (U.S.)
• Nabla Technologies (France)
• Hyro (U.S.)
• Orbita, Inc. (U.S.)
• Buoy Health, Inc. (U.S.)
• Teckel Medical (Spain)

Segments

Software/Platform Segment Dominated Due to Scalable Deployment Across Healthcare Workflows

By component, the market is divided into software/platform and services. The software/platform segment holds the largest market share as conversational AI is primarily delivered through scalable platforms like AI-enabled chatbots, voice assistants, and EHR-integrated tools.

Cloud-Based Segment Growth Boosted by Scalable Deployment and Easier Integration

By deployment, the market is categorized into cloud-based, on-premise, and hybrid. The cloud-based segment leads due to its ability to scale across multiple facilities without significant internal infrastructure investment, while also supporting faster updates and easier integration.

NLP/Generative AI Segment Dominated Due to Its Core Role in Conversational Healthcare Interactions